|Bid||43.48 x 800|
|Ask||43.57 x 800|
|Day's Range||42.06 - 43.86|
|52 Week Range||27.35 - 55.85|
|Beta (5Y Monthly)||1.21|
|PE Ratio (TTM)||82.09|
|Earnings Date||Nov 02, 2020 - Nov 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||62.20|
BioTelemetry, Inc. (NASDAQ:BEAT), is not the largest company out there, but it received a lot of attention from a...
Ladies and gentlemen, good afternoon, and thank you for joining us for the BioTelemetry Second Quarter 2020 Earnings Conference Call. Such statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company in the future, to be materially different from the statements that the company's executives may make today. It is now my pleasure to turn the floor over to your host, Mr. Joseph Capper, President and CEO of BioTelemetry.
BioTelemetry (BEAT) delivered earnings and revenue surprises of 191.67% and 15.34%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?